Reports for TEVA CANADA LIMITED

Company Name

TEVA CANADA LIMITED

Totals

Shortage reports

2928

Actual shortage: 212 (7%)
Anticipated shortage: 0 (0%)
Avoided shortage: 10 (0%)
Resolved: 2706 (92%)

Discontinuation Reports

300

To be discontinued: 2 (1%)
Discontinued: 298 (99%)
Reversed: 0 (0%)

Late reports

362 (11%)

Overdue reports

85 (40%)

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-12-01 2022-12-22 176821
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2023-04-27 2023-06-09 190731
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2020-10-08 2020-10-15 126029
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2020-12-10 2021-01-28 129978
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2021-03-25 2021-05-06 136292
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2020-11-19 2021-01-28 128597
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2023-02-09 2023-06-09 184225
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2022-03-04 2022-03-24 156064
TEVA-DEXTROAMPHETAMINE SR 15MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-01-25 2024-04-25 217240
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2024-02-01 2024-04-25 218145
TEVA-DEXTROAMPHETAMINE SR 10MG CAPSULE (SUSTAINED-RELEASE) Resolved 2018-12-04 2019-06-04 68589
ACT DILTIAZEM CD 300MG CAPSULE (EXTENDED RELEASE) Resolved 2018-09-12 2023-04-28 61340
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-26 2021-05-26 82555
ACT DILTIAZEM CD Actual shortage 2018-12-04 2018-12-04 68602
ACT DILTIAZEM CD 120MG CAPSULE (EXTENDED RELEASE) Resolved 2019-04-26 2021-05-26 82552
ACT DILTIAZEM CD 180MG CAPSULE (EXTENDED RELEASE) Resolved 2017-05-10 2017-09-19 9901
TEVA-DILTIAZEM T 360MG CAPSULE (EXTENDED RELEASE) Resolved 2017-03-17 2018-10-11 3362
ACT ENALAPRIL 8MG TABLET Resolved 2024-04-18 2024-08-30 225486
ACT ENALAPRIL 16MG TABLET Resolved 2018-09-12 2019-08-06 61349
ACT ENALAPRIL 8MG TABLET Resolved 2021-02-25 2021-09-16 134743

Showing 61 to 80 of 2928

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION 40MG POWDER FOR SOLUTION Discontinued 2021-09-23 2021-09-23 146061
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-04-11 2019-04-11 81321
NOVAMOXIN 500MG CAPSULE Discontinued 2017-06-27 2017-06-27 14046
NOVAMOXIN 250MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81316
NOVAMOXIN 250MG CAPSULE Discontinued 2020-01-24 2020-01-24 104289
NOVAMOXIN 25MG GRANULES FOR SUSPENSION Discontinued 2019-04-11 2019-04-11 81393
NOVAMOXIN 125MG TABLET (CHEWABLE) Discontinued 2019-10-25 2019-10-26 97251
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63955
NOVASEN 325MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63959
NOVASEN 650MG TABLET (DELAYED-RELEASE) Discontinued 2018-10-12 2018-10-12 63964
NOVO-PROFEN 400MG TABLET Discontinued 2018-10-19 2018-10-19 64920
NOVO-PROFEN 200MG TABLET Discontinued 2019-04-11 2019-04-11 81310
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.5G 4G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210194
PIPERACILLIN / TAZOBACTAM POWDER FOR INJECTION 0.375G 3G POWDER FOR SOLUTION Discontinued 2023-11-15 2023-11-15 210191
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64589
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64592
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64615
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64623
RATIO-ATORVASTATIN Discontinued 2018-10-17 2018-10-17 64626
RATIO-ATORVASTATIN Discontinued 2018-10-19 2018-10-19 64852

Showing 81 to 100 of 300